Anxiety and depression among adults with haemophilia A: Patient and physician reported symptoms from the real‐world European CHESS II study
Ferri Grazzi, Enrico ; Blenkiron, Thomas ; Hawes, Charles ; Camp, Charlotte ; O'Hara, Jamie ; Burke, Tom ; O'Brien, Gráinne
Ferri Grazzi, Enrico
Blenkiron, Thomas
Hawes, Charles
Camp, Charlotte
O'Hara, Jamie
Burke, Tom
O'Brien, Gráinne
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2024-03-20
Submitted Date
Collections
Other Titles
Abstract
Introduction: The physical pain and disability affecting many people with haemophilia A (PwHA) are known detractors from psychological wellbeing. While psychosocial support is considered a core tenet of the haemophilia comprehensive care structure, the extent to which mental health challenges are detected and monitored by the individuals treating haematologist remains relatively unexplored.
Aim: To describe prevalence of anxiety and depression in a real‐world cohort of adult PwHA and evaluate the congruence in reporting of anxiety or depression (A/D) between PwHA and their treating physicians.
Methods: Data for PwHA without inhibitors was drawn from the European ‘Cost of Haemophilia: A Socioeconomic Survey II’ (CHESS II) study. Haematologist‐indicated comorbidities of anxiety and depression were unified into a single A/D indicator. The EQ‐5D‐5L health status measure was used to characterise self‐reported A/D, with individuals stratified into two non‐mutually exclusive subgroups based on level of A/D reported (Subgroup A: ‘some’ or above; Subgroup B: ‘moderate’ or above).
Result: Of 381 PwHA with evaluable EQ‐5D‐5L responses, 54% (n = 206) self‐reported at least some A/D (Subgroup A) and 17% (n = 66) reported at least moderate A/D (Subgroup B). Patient‐physician congruence in A/D reporting was 53% and 76% for Subgroups A and B, respectively. Descriptive analysis suggested that individuals with physician‐ and/or self‐reported A/D experienced worse clinical outcomes (bleeding events, joint disease, chronic pain).
Conclusion: While adverse clinical outcomes appear to correlate with A/D, self‐reports of moderate–severe symptoms occasionally lacked formal recognition from treating physicians. Cross‐disciplinary surveillance of mental health issues could improve both psychological and clinical outcomes among PwHA.
Citation
Ferri Grazzi, E., Blenkiron, T., Hawes, C., Camp, C., O'Hara, J., Burke, T., & O'Brien, G. (2024). Anxiety and depression among adults with haemophilia A: Patient and physician reported symptoms from the real‐world European CHESS II study. Haemophilia, 30(3), 743-751. https://doi.org/10.1111/hae.14989
Publisher
Wiley
Journal
Haemophilia
Research Unit
DOI
10.1111/hae.14989
PubMed ID
PubMed Central ID
Type
Article
Language
Description
This article is not available on ChesterRep
Series/Report no.
ISSN
1351-8216
EISSN
1365-2516
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
Funder: Sanofi; FundRef: https://doi.org/10.13039/10.13039/100004339
Funder: BioMarin Pharmaceutical; FundRef: https://doi.org/10.13039/10.13039/100008484
